BeiGene, Ltd. (ONC) — Cash Flow Reinvestment Rate

Latest as of March 2026: 0.20x

BeiGene, Ltd. (ONC) has a Cash Flow Reinvestment Rate of 0.20x as of March 2026, reinvesting $40.94 Million (capex $40.91 Million plus investments $27.00K) from operating cash flow of $201.94 Million. See BeiGene, Ltd. (ONC) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.20x
(Capex + Investments) / Operating CF

Total Reinvested

$40.94 Million
Capex + Investments

Operating Cash Flow

$201.94 Million
USD

Capital Expenditures

$40.91 Million
USD

BeiGene, Ltd. Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for BeiGene, Ltd. across 3 annual periods. For the full cash flow conversion analysis, see cash flow conversion of BeiGene, Ltd..

Annual Cash Flow Reinvestment Rate for BeiGene, Ltd. (2013–2025)

Year-by-year capital reinvestment analysis for BeiGene, Ltd.. See BeiGene, Ltd. financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.17x $194.23 Million $1.13 Billion $185.84 Million ▼ -96.3%
2017 4.61x $58.73 Million $12.75 Million $58.73 Million ▲ +7005.2%
2013 0.06x $264.00K $4.07 Million $264.00K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow